Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing a dynamic pharmacophore model for HIV-1 integrase.

H A Carlson1, K M Masukawa, K Rubins

  • 1Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0365, USA. hcarlson@mccammon.ucsd.edu

Journal of Medicinal Chemistry
|June 8, 2000
PubMed
Summary

We developed a novel dynamic pharmacophore model for HIV-1 integrase, improving drug discovery by accounting for protein flexibility. This model successfully identified new inhibitors, outperforming static models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Nature medicine·2022
Same author

Genetic and phenotypic characteristics of Clostridium (Clostridioides) difficile from canine, bovine, and pediatric populations.

Anaerobe·2022
Same author

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Nature medicine·2022
Same author

NWChem: Past, present, and future.

The Journal of chemical physics·2020
Same author

Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.

European journal of medicinal chemistry·2019
Same author

RPYFMM: Parallel Adaptive Fast Multipole Method for Rotne-Prager-Yamakawa Tensor in Biomolecular Hydrodynamics Simulations.

Computer physics communications·2018

Area of Science:

  • Structural Biology
  • Computational Chemistry
  • Drug Discovery

Background:

  • HIV-1 integrase is a key target for antiviral therapy.
  • Existing pharmacophore models often fail due to protein flexibility.
  • Limitations exist with incomplete crystal structures for drug design.

Purpose of the Study:

  • To develop the first receptor-based dynamic pharmacophore model for HIV-1 integrase.
  • To improve drug discovery by incorporating protein flexibility.
  • To identify novel HIV-1 integrase inhibitors.

Main Methods:

  • Utilized molecular dynamics (MD) simulations to capture protein flexibility.
  • Employed multi-unit search for interacting conformers (MUSIC) simulations.
  • Compared dynamic model with static models and known inhibitors.

Related Experiment Videos

Main Results:

  • The dynamic pharmacophore model accurately describes known HIV-1 integrase inhibitors.
  • Static models failed to identify effective inhibitors.
  • Identified and experimentally validated new HIV-1 integrase inhibitors.

Conclusions:

  • Dynamic pharmacophore modeling is a superior approach for HIV-1 integrase inhibitor design.
  • This method overcomes limitations of static models and incomplete structures.
  • The identified compounds represent promising leads for new HIV therapies.